2Goldstein AL, Guha A, Zatz MM, et al. Purification and biologicalactivity of thymosin, a hormone of the thymus gland[j]. Proc NatlAcad Sci USA,1972,69(7):1800-1803.
3Ciancio A, Rizzetto M. Thymalfasin in the treatment of hepatitisB and C[J]. Ann NY Acad Sci,2010,1194:141-146.
4Garaci E, Pica F, Serafino A, et al. Thymosin alpha 1 and cancer:action on immune effector and tumor target cellsfJ]. Ann N YAcad Sci,2012,1269:26-33.
5Bozza S, Gaziano R, Bonifazi P, et al. Thymosin alpha 1 activatesthe TLR9/MyD88/IRF7-dependent murine cytomegalovirussensing for induction of anti-viral responses in vivo[J]. IntImmunol,2007,19( 11): 1261-1270.
6Serafino A, Pierimarchi P, Pica F, et al. Thymosin alpha 1 as astimulatory agent of innate cell-mediated immune response[J].Ann NY Acad Sci,2012,1270:13-20.
7Hadden JW. Immunodeficiency and cancer: prospects forcorrection[J]. Int Immunopharmacol,2003,3(8): 1061 -1071.
8WuJ, Zhou L, Liu J, et al. The efficacy of thymosin alpha 1 forsevere sepsis (ETASS): a multicenter, single-blind, randomizedand controlled trial [J]. Crit Care,2013,17(1):R8.
9Chien RN, Liaw YF. Drug therapy in patients with chronic type Bhepatitis[J]. J Formos Med Assoc, 1995,94(Suppl 1):1-9.
10Mutchnick MG, Appelman HD, Chung HT, et al. Thymosintreatment of chronic hepatitis B: a placebo-controlled pilot trial[J].Hepatology,1991,14(3):409-415.
